Shanghai Shyndec Pharmaceutical Co., Ltd. Sustainability Profile
Shanghai Shyndec Pharmaceutical Co., Ltd., commonly referred to as Shyndec, is a prominent player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong focus on research and development, Shyndec offers a diverse portfolio of products, including generic drugs and innovative formulations. Their commitment to quality and compliance with international standards has positioned them as a trusted partner in the pharmaceutical supply chain. Notable achievements include successful collaborations with global pharmaceutical companies, enhancing their reputation as a reliable source of pharmaceutical solutions.
DitchCarbon Score
How does Shanghai Shyndec Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Shyndec Pharmaceutical Co., Ltd.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai Shyndec Pharmaceutical Co., Ltd.'s reported carbon emissions
Shanghai Shyndec Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, the organisation's climate commitments and initiatives remain unclear. Without emissions data or reduction strategies, it is challenging to assess their environmental impact or commitment to sustainability. The pharmaceutical industry is increasingly focusing on reducing carbon footprints, and companies are encouraged to adopt science-based targets to align with global climate goals. However, without specific information from Shanghai Shyndec Pharmaceutical Co., Ltd., it is not possible to provide a detailed overview of their climate commitments or performance.
How Carbon Intensive is Shanghai Shyndec Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Shanghai Shyndec Pharmaceutical Co., Ltd.'s Location?
Shanghai Shyndec Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shanghai Shyndec Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
